OS Therapies unit OS Animal Health posts peer-reviewed data for OST-HER2 in canine osteosarcoma trial

OS Therapies Incorporated

OS Therapies Incorporated

OSTX

0.00
  • OS Animal Health, the wholly owned animal-health subsidiary of OS Therapies, reported peer-reviewed Phase 2 data for OST-HER2 with palliative radiation in frontline canine osteosarcoma.
  • Median overall survival was 159 days with OST-HER2 plus radiation versus 124 days for radiation alone (p=0.0237).
  • Two-year survival was 20% (3/15) with OST-HER2 plus radiation versus 1% (1/83) for radiation alone (p=0.00995).
  • OS Animal Health expects to seek alignment with the USDA on a conditional-approval pathway in Q3 2026.
  • OS Therapies reiterated plans to distribute OS Animal Health shares to its shareholders; OS Animal Health targets a Q3 2026 crowdfunding.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202606260740NEWSFILECNPR____20260626_302971_1) on June 26, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.